-
Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet) (Admin Supp Clinical Trial Not Allowed)
(PA-19-174)
National Cancer Institute
Application Receipt Date(s): March 1, 2018, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
(PAR-19-171)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): New applications: March 29, 2019; June 18, 2019; October 18, 2019; February 19, 2020; June 18, 2020; October 14, 2020; February 18, 2021; June 18, 2021; October 14, 2021
, by 5:00 PM local time of applicant organization.
Resubmission or, Revision applications: April 30, 2019; July 18, 2019; November 14, 2019; March 18, 2020; July 14, 2020; November 18, 2020, March 18, 2021; July 14, 2021; November 18, 2021, by 5:00 PM local time of applicant organization.
-
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)
(PAR-19-172)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed)
(PAR-19-173)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
(PAR-19-175)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): May 1, 2019, September 1,2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Methods Development for Cryogenic or Other Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R21 Clinical Trial Not Allowed)
(PAR-19-176)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
(PAR-19-177)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): May 31, 2019, by 5:00 PM local time at the applicant organization. All types of applications allowed for this funding opportunity are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)
(PAR-19-178)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): May 31, 2019, by 5:00 PM local time at the applicant organization. All types of applications allowed for this funding opportunity are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
(PAR-19-179)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): May 31, 2019, by 5:00 PM local time at the applicant organization. All types of applications allowed for this funding opportunity are due on this date.
-
Computational Models of Immunity (U01 Clinical Trial Not Allowed)
(RFA-AI-19-011)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed)
(RFA-CA-19-010)
National Cancer Institute
Application Receipt Date(s): April 1, 2019, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this funding opportunity announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-CA-19-011)
National Cancer Institute
Application Receipt Date(s): April 1, 2019, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
(RFA-DK-18-024)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 10, 2019 and November 20, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (U01 Clinical Trial Required)
(RFA-DK-18-025)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 10, 2019, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Data Coordinating Center for the Advanced Clinical Trials Consortium to Test Artificial Pancreas Device Systems (U24 Clinical Trial Not Allowed)
(RFA-DK-18-026)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 10, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity are due on this date.
-
Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)
(RFA-DK-18-027)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Developmental Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Not Allowed)
(RFA-DK-18-028)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
(RFA-DK-18-029)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed)
(RFA-FD-19-002)
Food and Drug Administration
Application Receipt Date(s): April 4, 2019 by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01) Clinical Trial Optional
(RFA-FD-19-005)
Food and Drug Administration
Application Receipt Date(s): April 4, 2019, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
High Quality Human Reference Genomes (HQRG) (U01 Clinical Trial Not Allowed)
(RFA-HG-19-002)
National Human Genome Research Institute
Application Receipt Date(s): April 2, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed)
(RFA-HG-19-003)
National Human Genome Research Institute
Application Receipt Date(s): April 2, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed)
(RFA-HG-19-004)
National Human Genome Research Institute
Office of Research on Women's Health
Application Receipt Date(s): April 2, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18)
(RFA-HS-19-001)
Agency for Healthcare Research and Quality
Application Receipt Date(s): March 25, 2019, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional)
(RFA-MH-20-200)
National Institute of Mental Health
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional)
(RFA-MH-20-201)
National Institute of Mental Health
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional)
(RFA-MH-20-202)
National Institute of Mental Health
Office of Research on Women's Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Human Three-Dimensional Cell Model Systems for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)
(RFA-NS-19-027)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): March 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
?Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.